CAH
Cardinal Health, Inc.
$229.54
장중 · Vol 27.4K · 52주 $145.87–$258.30 · 기준 2026. 8. 21. PM 3:59 ET
일봉 $234.27 · Aug 31, 2026
CAH 가격 추세
종가
$234.27
시가
$236.02
고가
$236.00
저가
$233.65
30초 브리핑
CAH 오늘의 판단 요약
보유 데이터를 비교 가능한 문장으로 해석한 요약입니다.
52주 범위의 74%
52주 범위 중간 구간으로 가격 위치만으로 방향성은 제한적입니다.
Forward P/E 16.7배
선행 P/E가 낮아 시장은 이익 증가를 반영하고 있습니다.
20일 평균의 0.7배
거래량은 최근 평균 범위입니다.
2026-11-05
실적 전후 변동성 확대 가능성이 있으므로 컨센서스 범위와 옵션 기대변동을 함께 보세요.
펀더멘털 기준 Sep 1, 2026 · 규칙 기반 요약이며 투자 조언이 아닙니다.
핵심 통계
CAH 일봉·펀더멘털 스냅샷 기준 주요 지표
펀더멘털 스냅샷 Sep 1, 2026
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
7000 Cardinal Place · Dublin, OH, United States · 직원 58,788명
시가총액
$54.57B
Trailing P/E
32.5
최근 12개월 이익 기준
Forward P/E
16.7
이익 증가 기대 반영
EPS (TTM)
$7.22
배당 수익률
0.88%
배당성향
28.3%
베타
0.52
시장보다 방어적
ROE
—
P/B
-18.96
EV/EBITDA
14.1
52주 범위
$145.87 – $258.30
현재 위치 74%
거래량
926.9K
20일 평균 1.26M · 0.7배
애널리스트 의견
매수 83%
총 18명 · 0m
DITM LEAPS Analysis
CAH 장기 DITM 콜옵션을 진입 적합도 순으로 비교
| Contract | Expiry | Strike | Price | Lev. | Delta | Extrinsic | Spread | IV | OI | Score | 상세 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAH280121C00155000 | 1/21/28 · 1.4Y | $155.00 | $84.75 | 2.5x | 0.9063 | 6.0% | 5.31% | 36.73% | 22 | 85.24 | |
| CAH280121C00130000 | 1/21/28 · 1.4Y | $130.00 | $113.20 | 1.9x | 0.9185 | 7.6% | 3.18% | 50.48% | 106 | 84.95 | |
| CAH280121C00135000 | 1/21/28 · 1.4Y | $135.00 | $105.50 | 2.0x | 0.9185 | 5.6% | 3.79% | 46.58% | 15 | 84.60 | |
| CAH280121C00140000 | 1/21/28 · 1.4Y | $140.00 | $101.00 | 2.1x | 0.9120 | 6.3% | 3.96% | 45.21% | 28 | 84.36 | |
| CAH280121C00150000 | 1/21/28 · 1.4Y | $150.00 | $95.50 | 2.2x | 0.8811 | 11.4% | 4.19% | 48.27% | 42 | 78.10 | |
| CAH280121C00160000 | 1/21/28 · 1.4Y | $160.00 | $87.75 | 2.3x | 0.8616 | 15.0% | 3.99% | 46.41% | 99 | 75.62 | |
| CAH280121C00165000 | 1/21/28 · 1.4Y | $165.00 | $83.50 | 2.4x | 0.8513 | 16.6% | 4.79% | 45.41% | 5 | 70.77 | |
| CAH280121C00170000 | 1/21/28 · 1.4Y | $170.00 | $79.75 | 2.5x | 0.8390 | 19.0% | 5.64% | 45.02% | 30 | 70.01 | |
| CAH280121C00180000 | 1/21/28 · 1.4Y | $180.00 | $73.00 | 2.6x | 0.8150 | 25.2% | 4.11% | 43.35% | 70 | 66.35 | |
| CAH280121C00185000 | 1/21/28 · 1.4Y | $185.00 | $68.50 | 2.8x | 0.8031 | 27.6% | 5.84% | 42.13% | 8 | 61.73 | |
| CAH280121C00190000 | 1/21/28 · 1.4Y | $190.00 | $65.00 | 2.9x | 0.7893 | 31.4% | 6.15% | 41.45% | 23 | 59.75 | |
| CAH280121C00195000 | 1/21/28 · 1.4Y | $195.00 | $59.25 | 3.1x | 0.7801 | 33.1% | 7.59% | 38.49% | 55 | 59.47 | |
| CAH280121C00200000 | 1/21/28 · 1.4Y | $200.00 | $58.50 | 3.0x | 0.7604 | 40.8% | 5.13% | 39.88% | 119 | 54.95 |
재무제표
CAH 연간 손익·현금흐름·재무상태
매출 성장률
-1.9%
최근 연간 YoY
EPS 성장률
+87.0%
최근 연간 YoY
영업이익률
1.0%
최근 연간
FCF 마진
0.8%
잉여현금흐름 / 매출
매출 추세
순이익 추세
잉여현금흐름 추세
| 항목 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| 매출 | $222.58B-1.9% | $226.83B+10.7% | $204.98B+13.0% | $181.33B |
| 매출총이익 | $8.17B+10.2% | $7.41B+7.9% | $6.87B+6.0% | $6.48B |
| 영업이익 | $2.32B+9.0% | $2.13B+19.1% | $1.79B+8.6% | $1.65B |
| 순이익 | $1.56B+83.2% | $852.00M+158.2% | $330.00M+135.2% | -$938.00M |
| 희석 EPS | $6.45+87.0% | $3.45+245.0% | $1.00+129.9% | $-3.35 |
| EBITDA | $3.11B+58.3% | $1.96B+36.3% | $1.44B+2516.4% | $55.00M |
| 영업현금흐름 | $2.40B-36.3% | $3.76B+32.3% | $2.84B-10.4% | $3.17B |
| 잉여현금흐름 | $1.85B-43.1% | $3.25B+37.6% | $2.36B-15.2% | $2.79B |
| 총자산 | $53.12B+17.7% | $45.12B+4.1% | $43.35B-1.2% | $43.88B |
| 총부채 | $8.53B+67.5% | $5.09B+8.3% | $4.70B-11.6% | $5.32B |
최신 연도 우선 · 작은 퍼센트는 직전 연도 대비 변화입니다.
캘린더
CAH 실적·배당 일정
매출 하단
$65.08B
EPS 하단
$2.88
매출 상단
$67.25B
배당 지급일
2026-10-15
D-44
실적 발표일
2026-11-05
D-65
EPS 상단
$3.06
매출 컨센서스
$66.67B
EPS 컨센서스
$2.94
배당락일
2026-10-01
D-30
최근 배당
| 배당락일 | 주당 배당 |
|---|---|
| Jul 1, 2026 | $0.5160 |
| Apr 1, 2026 | $0.5110 |
| Jan 2, 2026 | $0.5110 |
| Oct 1, 2025 | $0.5110 |
| Jul 1, 2025 | $0.5110 |
| Apr 1, 2025 | $0.5060 |
| Jan 2, 2025 | $0.5060 |
| Oct 1, 2024 | $0.5060 |
뉴스
CAH 관련 최신 기사
실적AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
AbbVie trades cheaper but carries heavy revenue concentration; Johnson & Johnson boasts a fortress balance sheet and wider portfolio.
Motley Fool · Aug 29, 2026
- 실적
Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Amgen generated $8.1 billion in free cash flow in 2025, with a 21% net margin, while Axsome is scaling rapidly but still unprofitable.
Motley Fool · Aug 29, 2026
실적How CVS' Pharmacy & Consumer Wellness Is Positioned for H2 2026
CVS Health carries strong pharmacy momentum into H2 2026, with rising prescription volume, Rite Aid gains and higher profit.
Zacks · Aug 27, 2026
실적What Cardinal Health (CAH)'s New US$5 Billion Buyback and Q4 Results Mean For Shareholders
In August 2026, Cardinal Health reported fourth‑quarter sales of US$63,672 million and net income of US$398 million, alongside a new US$4.00 billion revolving credit facility, a fresh US$5.00 billion share repurchase authorization, and a regular quarterly dividend of US$0.5158 per share. Together with over US$2.08 billion already spent to retire approximately 5.7% of its shares, this combination of earnings growth, expanded liquidity, and stepped-up capital returns highlights management’s...
Simply Wall St. · Aug 25, 2026
실적2 Profitable Stocks with Solid Fundamentals and 1 We Turn Down
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.
StockStory · Aug 25, 2026
실적McKesson Raises FY27 Guidance as Oncology and GLP-1 Growth Accelerate
McKesson raises fiscal 2027 EPS guidance as oncology, GLP-1 volumes and specialty distribution drive faster profit growth despite cash-flow pressure.
Zacks · Aug 24, 2026
- 실적
Is McKesson Stock Worth Buying as Growth Meets a Premium Valuation?
McKesson's double-digit earnings growth, specialty expansion and capital returns support the story, but a premium valuation leaves less room for error.
Zacks · Aug 24, 2026
제품·기술Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
CAH enters fiscal 2027 with strong specialty growth, but IRA pricing changes, GMPD challenges and heavy CapEx pose risks.
Zacks · Aug 24, 2026
- 실적
Winners And Losers Of Q2: Cardinal Health (NYSE:CAH) Vs The Rest Of The Healthcare Providers & Services Stocks
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the healthcare providers & services stocks, including Cardinal Health (NYSE:CAH) and its peers.
StockStory · Aug 24, 2026
제품·기술What to Know About the Latest Sale From Cardinal Health's Chief Accounting Officer
Mary C. Scherer reduced her direct equity but retains 2,811 shares after the stock delivered a 58% return over the past year.
Motley Fool · Aug 23, 2026
홀더
CAH 내부자·기관 보유 현황
최신 보고 목록 기준이며 실제 거래 시점과 보고일 사이에는 시차가 있습니다.
기관 보유
91.0%
기관 보유 (유동주식)
91.2%
내부자 보유
0.3%
기관 수
1,985
주요 기관 홀더
| 홀더 | 주식 수 | 평가액 | 지분 | 변동 | 보고일 |
|---|---|---|---|---|---|
| Blackrock Inc. | 26.49M | $6.22B | 11.4% | -7.0% | Jun 30, 2026 |
| Vanguard Capital Management LLC | 15.29M | $3.59B | 6.6% | 0.0% | Jun 30, 2026 |
| Wellington Management Group, LLP | 14.86M | $3.49B | 6.4% | 247.5% | Jun 30, 2026 |
| Vanguard Portfolio Management LLC | 13.72M | $3.22B | 5.9% | -0.1% | Jun 30, 2026 |
| State Street Corporation | 11.97M | $2.81B | 5.1% | -0.9% | Jun 30, 2026 |
| Geode Capital Management, LLC | 6.47M | $1.52B | 2.8% | -1.6% | Jun 30, 2026 |
| Invesco Ltd. | 4.74M | $1.11B | 2.0% | 35.0% | Jun 30, 2026 |
| Morgan Stanley | 4.63M | $1.09B | 2.0% | -6.6% | Jun 30, 2026 |
| WCM Investment Management, LLC | 4.11M | $964.87M | 1.8% | 2.6% | Jun 30, 2026 |
| NORGES BANK | 3.73M | $874.29M | 1.6% | -3.1% | Jun 30, 2026 |
면책조항: 증시가격은 모든 주식 시장의 최신 증시가격을 표시하는 것은 아니며, 정보가 지연되거나 잘못될 수 있습니다. 거래 목적이나 조언이 아닌 정보 제공 목적으로만 제공됩니다.